Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ahmed Mostafa Abd-Elaziz, Lecturer
Department of Clinical Oncology, Faculty of Medicine, Minia University, Minia, Egypt.
Study Director - Asmaa N. Iqbal Ahmed, Demonstrator
Clinical Pharmacy Department, Faculty of Pharmacy, Minia University, Minia, Egypt.
Principal Investigator - Eman M. Sadek, Lecturer
Clinical pharmacy Department, Faculty of Pharmacy, Minia University, Minia, Egypt.
Study Director - Engy A. Wahsh, Asst. Prof.
Clinical Pharmacy Department, Faculty of Pharmacy, October 6 University, Giza, Egypt
Study Director - Fatma M. Mady, Professor
Pharmaceutics department, Faculty of Pharmacy, Minia University, Minia, Egypt.
Study Chair - Noha Mahmood Abd-Allah, Lecturer
Department of Clinical Pathology, Faculty of Medicine, Minia University, Minia, Egypt.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Minia Oncology Center
Minya, Egypt
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jun 2024
- Primary completion
- 28 Jan 2025
- Completion
- 27 Mar 2025
- Last update posted
- 30 Mar 2025
- Registered enrollment
- 60
- Registry id
- NCT06459193
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.